RAPT Therapeutics’ (RAPT) Buy Rating Reaffirmed at HC Wainwright
RAPT Therapeutics (NASDAQ:RAPT – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $10.00 target price on the stock. HC Wainwright also issued estimates for RAPT Therapeutics’ FY2026 earnings at ($0.91) EPS. Several other research firms […]
RAPT Therapeutics (NASDAQ:RAPT – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They currently have a $10.00 target price on the stock. HC Wainwright also issued estimates for RAPT Therapeutics’ FY2026 earnings at ($0.91) EPS. Several other research firms […]
